EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Integrated Transcriptomic and Functional Analyses Identify SERPINE1 as a Ferroptosis-Associated Mediator of Glioblastoma Radioresistance

Yuhang Wang, Yanting Li, Meng Dong, Chao Zeng, Zhuanmei Jin, Qiuning Zhang, Wenzhen Yuan

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl53668 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, 2026. Written by Yuhang Wang and 6 co-authors. Institution: The First School of Clinical Medicine, Lanzhou University, 730000 Lanzhou, Gansu, China. Major MEDLINE topics: Glioblastoma, Ferroptosis, Plasminogen Activator Inhibitor 1, Radiation Tolerance. 44 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Radiotherapy failure remains a major challenge in glioblastoma (GBM), yet the stress-adaptive programs that enable tumor cells to survive irradiation-induced lethal injury remain incompletely defined. This study investigated whether serpin family E member 1 (SERPINE1) contributes to GBM radioresistance by modulating ferroptosis-associated lipid peroxidation, a process linked to iron-dependent oxidative injury.

Methods

Radiotherapy-treated GBM cohorts from TCGA (n = 93; 56 radiosensitive and 37 radioresistant cases), the Chinese Glioma Genome Atlas (CGGA)-325 (n = 100), and CGGA-693 (n = 193), as well as Clinical Proteomic Tumor Analysis Consortium (CPTAC) protein data and the Gene Expression Omnibus (GEO) single-cell RNA sequencing (scRNA-seq) dataset GSE131928, were analyzed using differential gene expression, weighted gene co-expression network analysis (WGCNA), machine-learning feature selection, FerrDb annotation, survival analysis, pathway enrichment, scRNA-seq, and tumor microenvironment (TME) signature profiling. Radiosensitive disease was defined as a complete or partial response after radiotherapy, whereas radioresistant disease was defined as stable or progressive disease. Statistical analyses included Wilcoxon rank-sum tests, Spearman correlations, log-rank tests, multivariable Cox regression for overall survival (OS), and time-dependent receiver operating characteristic (ROC) analysis. Functional validation was performed in two GBM cell lines (U87 and U251) using SERPINE1 knockdown or overexpression, X-ray irradiation, ferrostatin-1 (Fer-1), and RAS-selective lethal 3 (RSL3).

Results

Integrative screening identified SERPINE1 as a ferroptosis-associated mediator of radioresistance and poor survival. SERPINE1 expression was elevated in primary GBM tumors (n = 199) compared with normal tissues (n = 18). SERPINE1-high tumors showed enrichment of ferroptosis driver, suppressor, and marker gene signatures, consistent with a ferroptosis-stressed but ferroptosis-defensive state. Single-cell analysis localized SERPINE1 mainly to mesenchymal-like malignant cells, where high expression co-occurred with hypoxia, extracellular matrix remodeling, radioresistance, and ferroptosis-defense programs. In U87 cells, SERPINE1 knockdown enhanced radiosensitivity and increased irradiation-induced lipid reactive oxygen species (ROS), malondialdehyde (MDA), and Fe2+ accumulation, whereas SERPINE1 overexpression in U251 cells attenuated ferroptosis-associated lipid peroxidation and iron accumulation and improved post-irradiation cell survival. Fer-1 partially rescued the radiosensitizing effect of SERPINE1 depletion, whereas RSL3 weakened SERPINE1-mediated radioprotection.

Conclusions

SERPINE1 appears to link mesenchymal adaptation, redox stress regulation, and ferroptosis-associated lipid peroxidation defense in GBM radioresistance. These findings support further evaluation of SERPINE1-guided ferroptosis-based radiosensitization strategies. Public datasets were obtained from TCGA, CGGA, CPTAC, and GEO (GSE131928).

Subjects

MeSH terms (MEDLINE)

GlioblastomaFerroptosisPlasminogen Activator Inhibitor 1Radiation ToleranceBrain NeoplasmsTranscriptomeHumansGene Expression Regulation, NeoplasticCell Line, TumorGene Expression Profiling

Author keywords

ferroptosisglioblastomaplasminogen activator inhibitor 1radiation toleranceradiotherapysingle-cell gene expression analysistumor microenvironment

Substances

Plasminogen Activator Inhibitor 1SERPINE1 protein, human

Authors and institutions

  • The First School of Clinical Medicine, Lanzhou University, 730000 Lanzhou, Gansu, China.
  • Institute of Modern Physics, Chinese Academy of Sciences, 730000 Lanzhou, Gansu, China.

Cite

APA

Wang, Y., Li, Y., Dong, M., Zeng, C., Jin, Z., Zhang, Q., & Yuan, W. (2026). Integrated Transcriptomic and Functional Analyses Identify SERPINE1 as a Ferroptosis-Associated Mediator of Glioblastoma Radioresistance. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl53668

Vancouver

Wang Y, Li Y, Dong M, Zeng C, Jin Z, Zhang Q, et al. Integrated Transcriptomic and Functional Analyses Identify SERPINE1 as a Ferroptosis-Associated Mediator of Glioblastoma Radioresistance. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl53668

BibTeX
@article{Wang2026,
  author = {Wang, Yuhang and Li, Yanting and Dong, Meng and Zeng, Chao and Jin, Zhuanmei and Zhang, Qiuning and Yuan, Wenzhen},
  title = {Integrated Transcriptomic and Functional Analyses Identify SERPINE1 as a Ferroptosis-Associated Mediator of Glioblastoma Radioresistance},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl53668}
}
Start for free →